• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes

tetano

Editor, Senior Moderator
PLoS One


. 2021 Aug 11;16(8):e0255999.
doi: 10.1371/journal.pone.0255999. eCollection 2021.
COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes


Naila Shoaib[SUP] 1 2 [/SUP], Naila Noureen[SUP] 1 2 3 [/SUP], Rimsha Munir[SUP] 1 4 [/SUP], Farhad Ali Shah[SUP] 1 2 [/SUP], Noshaba Ishtiaq[SUP] 1 [/SUP], Nazia Jamil[SUP] 5 [/SUP], Rida Batool[SUP] 5 [/SUP], Mohammad Khalid[SUP] 4 [/SUP], Ihsan Khan[SUP] 3 [/SUP], Naser Iqbal[SUP] 3 [/SUP], Nousheen Zaidi[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: The primary goal of the presented cross-sectional observational study was to determine the clinical and demographic risk factors for adverse coronavirus disease 2019 (COVID-19) outcomes in the Pakistani population.
Methods: We examined the individuals (n = 6331) that consulted two private diagnostic centers in Lahore, Pakistan, for COVID-19 testing between May 1, 2020, and November 30, 2020. The attending nurse collected clinical and demographic information. A confirmed case of COVID-19 was defined as having a positive result through real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay of nasopharyngeal swab specimens.
Results: RT-PCR testing was positive in 1094 cases. Out of which, 5.2% had severe, and 20.8% had mild symptoms. We observed a strong association of COVID-19 severity with the number and type of comorbidities. The severity of the disease intensified as the number of comorbidities increased. The most vulnerable groups for the poor outcome are patients with diabetes and hypertension. Increasing age was also associated with PCR positivity and the severity of the disease.
Conclusions: Most cases of COVID-19 included in this study developed mild symptoms or were asymptomatic. Risk factors for adverse outcomes included older age and the simultaneous presence of comorbidities.
 
Back
Top Bottom